BFEC
GH icon

Benjamin F. Edwards & Company’s Guardant Health GH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3K Sell
100
-100
-50% -$2.33K ﹤0.01% 1986
2024
Q1 		$4K Sell
200
-176
-47% -$3.77K ﹤0.01% 1909
2023
Q4 		$10K Sell
376
-225
-37% -$5.9K ﹤0.01% 1656
2023
Q3 		$18K Hold
601
– – ﹤0.01% 1277
2023
Q2 		$22K Sell
601
-100
-14% -$2.87K ﹤0.01% 1254
2023
Q1 		$16K Sell
701
-100
-12% -$2.86K ﹤0.01% 1313
2022
Q4 		$22K Sell
801
-263
-25% -$12K ﹤0.01% 1258
2022
Q3 		$57K Hold
1,064
– – ﹤0.01% 1020
2022
Q2 		$43K Sell
1,064
-252
-19% -$12.5K ﹤0.01% 1078
2022
Q1 		$87K Sell
1,316
-21
-2% -$1.44K ﹤0.01% 896
2021
Q4 		$134K Buy
1,337
+130
+11% +$13.4K 0.01% 811
2021
Q3 		$151K Sell
1,207
-210
-15% -$25K 0.01% 753
2021
Q2 		$176K Hold
1,417
– – 0.01% 677
2021
Q1 		$216K Sell
1,417
-4
-0.3% -$605 0.01% 653
2020
Q4 		$183K Buy
1,421
+45
+3% +$5.18K 0.01% 669
2020
Q3 		$154K Sell
1,376
-24
-2% -$2.19K 0.01% 652
2020
Q2 		$114K Sell
1,400
-297
-18% -$23.9K 0.01% 706
2020
Q1 		$118K Buy
1,697
+197
+13% +$15.1K 0.01% 644
2019
Q4 		$117K Hold
1,500
– – 0.01% 750
2019
Q3 		$96K Hold
1,500
– – 0.01% 752
2019
Q2 		$129K Hold
1,500
– – 0.01% 634
2019
Q1 		$115K Buy
1,500
+800
+114% +$44.4K 0.01% 646
2018
Q4 		$26K Buy
+700
New +$25.8K ﹤0.01% 1023

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Benjamin F. Edwards & Company's GH Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Guardant Health (GH) stake by 50% in Q2 2024, selling an estimated $2.33K and leaving 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Benjamin F. Edwards & Company first reported a position in GH in Q4 2018 and has held it in 23 quarters since. The position peaked at $216K in Q1 2021. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

  • Benjamin F. Edwards & Company held 100 shares of Guardant Health worth $3K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 100 Guardant Health shares in Q2 2024, an estimated $2.33K.
  • Guardant Health made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1986 holding.
  • Benjamin F. Edwards & Company first reported a position in Guardant Health in Q4 2018 and has held it in 23 quarters since.
  • Benjamin F. Edwards & Company's Guardant Health position peaked at $216K in Q1 2021.
  • 282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.